What is your brain tumor story? Click here to share it. Your story matters.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
Discover how we’re closer to tripling our investment in research thanks to your support of Meet Hope Head On!
Sangami Pugazenthi is rewarded for her research exploring biological processes behind radiation resistance in grade 2 meningiomas.
Read our top takeaways from the Society for Neuro-Oncology (SNO) Annual Meeting, the world’s largest gathering of neuro-oncology experts.
The ABTA is proud to announce eight recipients of the Medical Student Summer Fellowship grants.
A first-in-class targeted therapy for low-grade glioma could gain FDA approval as early as spring 2024. Here are three things you should know about the emerging drug “vorasidenib.”
Read three takeaways from the American Association for Cancer Research annual meeting in April.
Always free for patients & caregivers
